CROI 2009: a few key presentations on antiretroviral therapy.
Gallant
Joel E
JE
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D015224:Dideoxynucleosides / Q000009:adverse effects; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors; D006801:Humans; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D000099227:Abacavir